Navigation Links
Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth
Date:4/26/2012

was adopted by the European Commission on March 26, 2012. Shire now has two EMA approved facilities - Alewife in Cambridge, Massachusetts, as well as the new Lexington facility - in which to manufacture VPRIV drug substance.

Shire has received a Complete Response letter from the US Food and Drug Administration ("FDA") regarding production of VPRIV drug substance at Lexington. Shire is working closely with the FDA to address their questions and resolve any outstanding issues to the satisfaction of the agency.

Notwithstanding the ongoing discussions with the FDA, Shire continues to supply VPRIV to US patients through its existing approved US manufacturing facility at Alewife and has the capacity to meet the anticipated demand for VPRIV from existing and new patients both in the US and globally, recognizing that US inventory levels will be below target levels until the Lexington facility is approved by the FDA.

VYVANSE - for the treatment of Attention Deficit Hyperactivity Disorder ("ADHD")

  • On March 6, 2012 Shire announced that it is initiating two Phase 4 clinical trials to compare VYVANSE Capsules to CONCERTA® Extended-Release Tablets. These prospectively designed head-to-head clinical trials will provide important information for physicians, patients, caregivers, and payors to make informed choices, and have been designed to explore differences in efficacy between VYVANSE and CONCERTA in adolescents aged 13 to 17 with ADHD. Together the two trials will enroll approximately 1,000 patients, and results are expected in the second half of 2013.

FOSRENOL® - for the treatment of Hyperphosphatemia in end stage renal disease

  • On March 8, 2012 Shire announced that it has received approval through the European Decentralised Procedure for an oral powder formulation of FOSRENOL. The oral powder formulation
    '/>"/>

SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related medicine technology :

1. Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients
2. Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy
3. Shire to Present Additional Scientific Data on ADHD Treatment Portfolio at American Psychiatric Association Annual Meeting
4. Shires Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose
5. Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil
6. Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent
7. Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
8. Shire Announces Study Results of the Effects of INTUNIV(TM) (Guanfacine) Extended Release on Secondary Measures in Children with ADHD and Oppositional Symptoms
9. Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week
10. Shire has Filed a Treatment Protocol for Velaglucerase Alfa for Gaucher Disease
11. Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... Inc. (Nasdaq: NXTM ), a leading manufacturer of ... that exceed the top end of its guidance range. ... 2015 increased 10 percent to $79.5 million, compared with ... 2014. The Company,s revenue guidance range for the first ... was driven by outperformance in the System One segment ...
(Date:5/6/2015)... Eli Lilly and Company (NYSE: LLY ... delivery and device innovation center in Cambridge, ... help attract top scientists and bioengineers, as well as ... The Lilly Cambridge Innovation Center, a makerspace located in ... organizations to explore how emerging technologies and connectivity can ...
(Date:5/6/2015)... 2015 According to a ... Market by Technology (Precipitation, Dialysis, Electrophoresis, Western Blotting, ... Kits, Reagents, Resins) by Application & End User ...  the global Protein Purification and Isolation Market was ... is expected to reach $ 6,370 Million by ...
Breaking Medicine Technology:NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 2NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 3NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 4NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 5NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 6NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 7NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 8NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 9NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 10NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 11Eli Lilly and Company Reveals Plan for Innovation Center in Cambridge, Massachusetts 2Eli Lilly and Company Reveals Plan for Innovation Center in Cambridge, Massachusetts 3Protein Purification and Isolation Market Worth $6,370 Million by 2020 2Protein Purification and Isolation Market Worth $6,370 Million by 2020 3Protein Purification and Isolation Market Worth $6,370 Million by 2020 4
... LAKES, N.J. and MONTREAL, Oct. 13, 2011 A ... gene testing analysis found that 38 percent of patients ... clots, heart attack and stroke—were also using another drug ... http://photos.prnewswire.com/prnh/20100609/MEDCOLOGO ) The analysis also showed that ...
... (NYSE AMEX: ULU ), announced today that it has ... company based in Switzerland, to license Altrazeal® for the European Union. ... the European Union rights to a subsidiary of Melmed Holdings AG ... for the license ULURU will receive a licensing payment and a ...
Cached Medicine Technology:Putting Gene Tests to Use: More Than a Third of Patients Cannot Properly Metabolize Plavix® 2Putting Gene Tests to Use: More Than a Third of Patients Cannot Properly Metabolize Plavix® 3Putting Gene Tests to Use: More Than a Third of Patients Cannot Properly Metabolize Plavix® 4ULURU Inc. Announces Altrazeal® Agreement for the European Market 2ULURU Inc. Announces Altrazeal® Agreement for the European Market 3
(Date:5/6/2015)... 06, 2015 Established by the Arthritis ... the estimated 46 million Americans who suffer from arthritis. ... medications to alleviate their symptoms. Medicationdiscountcard.com is proud to ... patients money on the costs of these necessary prescriptions. ... to treat the pain and inflammation in the joints ...
(Date:5/6/2015)... 06, 2015 The Jefferson Awards ... to activating and celebrating public service, announced today ... Health, as an Outstanding Employee Volunteer Organization. Champions ... Awards Foundation, are dedicated to building a culture ... decade, Highmark Health has recognized employees who volunteer ...
(Date:5/6/2015)... Stout Industries is owned and operated by ... Texas fire departments. Stout Industries recently developed Fire-ground Injury ... to these fire safety devices. The departure lights are ... turned on. They light the area within 50 feet of ... the roof, preventing leg and ankle injuries. In 2013 ...
(Date:5/6/2015)... NH (PRWEB) May 06, 2015 Launch Corporation, ... has opened its new Nashua location at 17 Tanguay Avenue. ... will be the duo’s second Launch location in New England. ... their new team,” said Rob Arnold, founder, co-owner and CEO ... location and we look forward to seeing them continue to ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 The SGNY ... New York City, announced today that it was named ... for a presentation video produced on behalf of Intarcia ... the category of motion graphics. , The competition sponsored ... received over 6000 entries from 22 countries. The ...
Breaking Medicine News(10 mins):Health News:Medicationdiscountcard.com Provides Access to Drug Coupons for Arthritis Awareness Month 2Health News:Medicationdiscountcard.com Provides Access to Drug Coupons for Arthritis Awareness Month 3Health News:The Jefferson Awards Foundation Honors Highmark Health 2Health News:The Jefferson Awards Foundation Honors Highmark Health 3Health News:The Jefferson Awards Foundation Honors Highmark Health 4Health News:Kickstarter for FIRE Lights, the New Fire Safety Devices 2Health News:Jump Up and Celebrate: Launch Trampoline Park Opens in Nashua, NH 2Health News:The SGNY Group Wins Platinum Hermes Creative Award 2
... 23 Niutang Chemical, a leading,global manufacturer of ... Alan Turner to lead its new office in ... Ltd., Mr. Turner will,spearhead all of Nuitang,s sales ... acid. He will particularly focus on the company,s,fast-growing ...
... WellPoint, Inc. (NYSE:,WLP) today announced the appointment ... segment, effective July 8, 2008., In his ... WellPoint,s,Individual Business segment, which currently serves more than ... add the quality of experience and,strategic expertise that ...
... individuals had more advanced disease and were less likely ... News) -- Low socioeconomic status increases a cancer patient,s ... on almost 14,000 breast, prostate and colorectal patients in ... patients with low socioeconomic status had more advanced cancers ...
... discovery holds promise as a treatment target for this diverse ... Cancerous myeloma cells are so "addicted" to a gene known ... has revealed. , Reducing the activity of the gene by ... compromising other healthy activities, said scientists reporting in the current ...
... AFAM ) announced today that it is scheduled to ... of market on June 27,according to a preliminary list of ... B. Yarmuth, President and CEO of Almost Family, Inc., stated,"We ... end of June as,it will provide greater awareness and visibility ...
... Before Disaster ... Fans, Players and Coaches, CLEVELAND, June 23 The ... -- able to,detect hidden flaws or developed stress within Major ... -- will be introduced as,BatteryMate(TM) on June 27, 2008, at ...
Cached Medicine News:Health News:Niutang Recruits Seasoned Executive to Open U.K. Office 2Health News:WellPoint Appoints Raj G. Bal as President of Individual Business 2Health News:Poorer Patients Have Poorer Survival After Cancer Diagnosis 2Health News:One Gene May Be Key to Myeloma 2Health News:One Gene May Be Key to Myeloma 3Health News:Almost Family, Inc. Set to Join to Russell 2000(R) Index 2Health News:Bat Scan to the Rescue: New Clubhouse CT Scanner Helps Eliminate Exploding Bats 2Health News:Bat Scan to the Rescue: New Clubhouse CT Scanner Helps Eliminate Exploding Bats 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: